DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

B. Riley FBR Upgrades Global Medical REIT to Buy, Lowers Price Target to $12

B. Riley FBR analyst Bryan Maher upgrades Global Medical REIT (NYSE:GMRE) from Neutral to Buy and lowers the price target from $16 to $12.

Benzinga · 03/18/2020 11:14

B. Riley FBR analyst Bryan Maher upgrades Global Medical REIT (NYSE:GMRE) from Neutral to Buy and lowers the price target from $16 to $12.